1 IN. DI LETTURA
Dec 28 (Reuters) - Mylan Inc MYL.N said its Mylan Pharmaceuticals Inc unit received final approval from U.S. health regulators for its generic version of Pfizer Inc's (PFE.N) allergy drug Zyrtec.
The approval is for Cetirizine Hydrochloride tablets, 5 mg and 10 mg, and the tablets will be shipped immediately, the company said in a statement.
Zyrtec had U.S. sales of about $1.4 billion for the 12 months ended Sept. 30. (Reporting by Purwa Khandelwal in Bangalore; Editing by Gopakumar Warrier)